Market Advocacy to Reduce Newborn Infections and Deaths in Bangladesh

This case study examines the use of advocacy to reduce newborn infections in Bangladesh, specifically the market advocacy efforts by PATH and the Bangladesh Pediatric Association to engage public and private stakeholders to understand the importance of 7.1 percent chlorhexidine digluconate use.

Corporate author(s): PATH; Bangladesh Pediatric Association

Publication date: December 2017

Market Advocacy to Reduce Newborn Infections and Deaths in Bangladesh

- PDF

Hard copies are not available.
View Resource